Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,837 total articles

Viasat Sets May 28, 2026 for Fourth Quarter and Fiscal Year 2026 Financial Results Conference Call and Webcast

Viasat Sets May 28, 2026 for Fourth Quarter and Fiscal Year 2026 Financial Results Conference Call and Webcast

Viasat, a global satellite communications company, announced it will release its fourth quarter and fiscal year 2026 financial results on May 28, 2026, after market close. The company will hold a conference call and webcast to discuss the results. Viasat recently completed the acquisition of Inmarsat, enhancing its global communications capabilitie…

Calidi Biotherapeutics Provides Required NYSE American Disclosure

Calidi Biotherapeutics Provides Required NYSE American Disclosure

Calidi Biotherapeutics has released a disclosure regarding its audited financial statements for the year ended December 31, 2025, which include an explanatory paragraph about continuing as a going concern. This is a regulatory disclosure requirement and does not reflect a change in the company's filings. Calidi is developing targeted genetic medici…

Aperture AC Announces Closing of $102,000,000 Initial Public Offering, Including Partial Exercise of Underwriters’ Over-Allotment Option

Aperture AC Announces Closing of $102,000,000 Initial Public Offering, Including Partial Exercise of Underwriters’ Over-Allotment Option

Aperture AC successfully closed its initial public offering of 10.2 million units at $10 per unit, raising gross proceeds of $102 million. The units began trading on Nasdaq under the ticker APURU. The company is a blank check (SPAC) entity formed to pursue a merger or business combination in any industry or geographic area.

La Rosa Holdings Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

La Rosa Holdings Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

La Rosa Holdings Corp. announced it received a deficiency notice from Nasdaq for failing to timely file its quarterly and annual reports with the SEC. The company must submit a plan by June 15, 2026, to regain compliance or risk delisting. La Rosa plans to file the overdue reports or submit the compliance plan but warns that there is no assurance o…

LGI Homes Unveils Allen Townhomes: Modern Living North of Seattle

LGI Homes Unveils Allen Townhomes: Modern Living North of Seattle

LGI Homes announces the grand opening of Allen Townhomes, a 36-lot community in Arlington, Washington, designed with contemporary features and flexible floor plans. The company offers its CompleteHome Plus package at an affordable price with incentives such as interest rate buy downs and builder closing cost contributions, targeting strong demand f…

Alerus Financial Corporation Declares Cash Dividend on Common Shares

Alerus Financial Corporation Declares Cash Dividend on Common Shares

Alerus Financial Corporation declared a quarterly cash dividend of $0.22 per common share, marking a 4.76% increase from last year. This dividend payment underscores the company's strong financial performance and commitment to returning value to shareholders. The dividend will be payable on July 10, 2026, to shareholders of record as of June 26, 20…

Apogee Acquisition Corp Announces the Separate Trading of Its Class A Ordinary Shares, Warrants and Rights, Commencing on May 28, 2026

Apogee Acquisition Corp Announces the Separate Trading of Its Class A Ordinary Shares, Warrants and Rights, Commencing on May 28, 2026

Apogee Acquisition Corp announced that from May 28, 2026, holders of its IPO units may elect to separately trade Class A ordinary shares, warrants, and rights on Nasdaq under symbols AACP, AACPW, and AACPR, respectively. The company, a special purpose acquisition company (SPAC), focuses on acquiring technology-related businesses. Units not separate…

NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million

NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million

Nanobiotix, a late-stage clinical biotechnology company, announced the full exercise of underwriters' over-allotment option in its global offering, resulting in gross proceeds of approximately $100 million. The proceeds will primarily fund the advancement of its Nanoprimer platform and other technologies, as well as support development of JNJ-1900 …

ACP Holdings Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about May 28, 2026

ACP Holdings Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about May 28, 2026

ACP Holdings Acquisition Corp., a US-listed blank check company focused on private credit investments, announced that its Class A ordinary shares and warrants will begin separate trading on Nasdaq around May 28, 2026. Holders of units sold in the IPO may elect to separate their units into individual shares and warrants. The company is seeking a bus…

SCYNEXIS Announces One-for-Eight Reverse Stock Split

SCYNEXIS Announces One-for-Eight Reverse Stock Split

SCYNEXIS, Inc., a clinical-stage biotechnology company, announced a one-for-eight reverse stock split effective May 29, 2026, to comply with Nasdaq's minimum bid price requirements. The reverse split will reduce the shares outstanding from approximately 79.5 million to 9.9 million, with no change to the company's market capitalization. The split-ad…

Japan Smaller Capitalization Fund, Inc. Announces Commencement of Tender Offer and Re-Leveling of Level Distribution Plan

Japan Smaller Capitalization Fund, Inc. Announces Commencement of Tender Offer and Re-Leveling of Level Distribution Plan

Japan Smaller Capitalization Fund, Inc. (NYSE: JOF) has announced a tender offer to repurchase up to 10% of its outstanding shares at 98% of NAV and has approved an 8% increase in its monthly distribution under its Level Distribution Plan. The tender offer will run from June 1 to July 1, 2026, and the monthly distribution increase results in a 9% y…

Orange County Bancorp, Inc. Declares Cash Dividend

Orange County Bancorp, Inc. Declares Cash Dividend

Orange County Bancorp, Inc., the parent company of Orange Bank & Trust Company and Orange Investment Advisors, announced a cash dividend of $0.18 per share, payable on June 15, 2026 to shareholders of record as of June 4, 2026. This reflects the company's commitment to returning value to its shareholders amid its growth to $2.6 billion in assets.

XTL Announces Receipt of Staff Delist Determination from Nasdaq

XTL Announces Receipt of Staff Delist Determination from Nasdaq

XTL Biopharmaceuticals Ltd. has received a formal notice from Nasdaq's Listing Qualifications Department indicating potential delisting from the Nasdaq Capital Market due to failure to timely file its Annual Report on Form 20-F for 2025, along with previously disclosed deficiencies involving minimum stockholders’ equity and bid price requirements. …

Maris-Tech Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance

Maris-Tech Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance

Maris-Tech Ltd. announced it received a notification from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement of $2.5 million, reporting equity of approximately $601,583 as of December 31, 2025. The company has until July 6, 2026 to submit a plan to regain compliance and may receive an extension if the plan is accepte…

Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis

Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis

Abivax SA disclosed its Q1 2026 financial results alongside promising three-year interim data from Study 108, a Phase 2a/2b open-label extension trial of obefazimod in moderately to severely active ulcerative colitis (UC) patients. The study shows durable clinical remission rates of 68% after dose de-escalation to 25 mg over 144 weeks, with no new …